WCM
BSX icon

WealthTrak Capital Management’s Boston Scientific BSX Stock Holding History

WealthTrak Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-119
Closed -$12.8K – 192
2025
Q2 		$12.8K Sell
119
-1
-0.8% -$101 0.01% 171
2025
Q1 		$12.1K Buy
120
+50
+71% +$5.04K 0.01% 157
2024
Q4 		$6.25K Buy
+70
New +$6.16K 0.01% 188

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthTrak Capital Management's BSX Position: Q3 2025 in Review

WealthTrak Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 119 shares — an estimated $12.8K sold.

WealthTrak Capital Management first reported a position in BSX in Q4 2024 and held it in 3 quarters. The position peaked at $12.8K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • WealthTrak Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 119 Boston Scientific shares in Q3 2025, an estimated $12.8K.
  • WealthTrak Capital Management first reported a position in Boston Scientific in Q4 2024 and held it in 3 quarters.
  • WealthTrak Capital Management's Boston Scientific position peaked at $12.8K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.